Hsiao-Ching Li, M.D.
Associate Professor

Hsiao-Ching “Jenny” Li, M.D. is an Associate Professor in the Department of Internal Medicine at UT Southwestern, and a member of its Division of Hematology-Oncology. Her clinical interests include breast cancer and leukemia. She is Medical Director of the outpatient hematology clinics at Parkland Health and Hospital System (PHHS).

Originally from Taipei, Taiwan, Dr. LI holds a bachelor’s degree in physiological science from the University of California, Los Angeles. She received Her medical degree from Albany Medical College, and completed internal medicine residency training at the Los Angeles County-USC Medical Center. She then completed advanced training through a fellowship in clinical nutrition at UCLA and in hematology/oncology at Los Angeles County-USC Medical Center.

Board-certified in hematology and medical oncology, she joined the UT Southwestern Faculty in 2015. She serves as a member of UT Southwestern’s Institutional Review Board and PHHS’s Pharmacy and Therapeutics Committee, as well as Chair of the P&T Hematology/Oncology Subcommittee.

Dr. LI’s research interests include effectiveness of chemotherapy and improving clinical care. Her investigations have resulted in several publications in peer-reviewed journals.

She is a member of the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, and Health Volunteers Overseas.

Medical School

Albany Medical Center (1999)

Residency

Los Angeles County - Univ of Southern California Med Center (2002), Internal Medicine

Advanced Fellowship

UCLA Center for Human Nutrition (2003), Clinical Nutrition

Fellowship

Los Angeles County - Univ of Southern California Med Center (2006), Hematology Oncology

Featured Publications

Feasibility of a partial meal replacement

Huerta S, Li Z, Li Hc, Hu MS, Yu CA, Heber D. International Journal of Obesity Related Metab Disord 2004 28 1575-1579

Feasibility of a partial meal replacement plan for weight loss in low-income patients

Huerta S, Li Z, Li Hc, Hu MS, Yu CA, Heber D. International Journal of Obesity Related Metab Disord 2004 28 1575-1579

Gemcitabine and platinum-based chemotherapy in metastatic breast cancer

Li HC, Russell CA Oncology (Williston Park) 2004 18 17 - 22

Presentation and management of primary mediastinal large B-cell lymphoma: a retrospective cohort analysis.

Eule C, Arora N, Li HC, Sadeghi N, Acta Oncol 2020 Jul 59 7 786-788

Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital.

Keshvani N, Hon M, Gupta A, Brown TJ, Roy L, Marley E, Lindsey S, Johnson DH, Sadeghi N, Li HC, J Oncol Pract 2019 08 15 8 e644-e651

Clinicopathologic features, management, and outcomes of plasmablastic lymphoma: A 10-year experience.

Arora N, Eule C, Gupta A, Li HC, Sadeghi N, Am. J. Hematol. 2019 May 94 5 E127-E129

Decreasing Inappropriate Use of Rasburicase to Promote Cost-Effective Care.

Patel KK, Brown TJ, Gupta A, Roberts T, Marley E, Li HC, Sadeghi N J Oncol Pract 2019 Feb 15 2 e178-e186

Use of platelet and erythroid growth factors during induction chemotherapy for acute lymphoblastic leukaemia in a Jehovah's Witness.

Arora N, Gupta A, Li HC, Sadeghi N BMJ Case Rep 2018 Dec 11 1

Applying the "COST" (Culture, Oversight, Systems Change, and Training) Framework to De-adopt the Neutropenic Diet.

Gupta A, Brown TJ, Singh S, Sen A, Agrawal D, Li HC, Moriates C, Johnson DH, Sadeghi N Am. J. Med. 2018 Aug

Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.

Tumati V, Trivedi L, Li HC, Patel P, Scaglioni PP, Vusirikala M, Sadeghi N, Rizvi S, Chen W, Wachsmann J, Collins R, Desai NB Int. J. Radiat. Oncol. Biol. Phys. 2018 Apr 100 5 1126-1132

• Teacher of the Year
  Hematology Oncology Fellowship (2006)
• Teacher of the Year
  Hematology Oncology Fellowship (2005)
• Richard T. Beebe Fellowship in Medicine
  (1999)
• Trustees Prize in Pharmacology
  (1996)